Clinical efficacy and Safety of Remedeur tablets & ointment in internal hemorrhoids

To Evaluate the Efficacy of commercially available Ayurvedic tablets and ointment of Remedeur® in the management of Gudarsha w.s.r to Grade 1 and 2 internal hemorrhoids - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/096834

Enrollment

Registered

2025-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years of either sex. 2. Diagnosed with Grade I or II internal hemorrhoids with bleeding. 3. Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with Grade III or IV hemorrhoids. 2. Patients with a history of anorectal surgery. 3. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
1.Hemorrhoidal Disease Symptom Score 2.Short Health Scale HD 3.Anorectal Symptom Severity and Quality of Life Questionnaire Timepoint: Baseline, 2 weeks, 4 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Danish Javed

All India Institute of Medical Sciences Bhopal

danish.ayush@aiimsbhopal.edu.in09654978285

Outcome results